The current study presents a specific, accurate, simple, and rapid UPLC method for the determination of impurities present in cream and ointment formulations of betamethasone dipropionate (BMD). The analytical method was optimized using central composite design (CCD) prior to the method validation. Critical Process Parameters (CPPs) and Critical Quality Attributes (CQAs) were identified for the analytical method. A total of 17 experiments were carried out and verified the individual and interaction effects of CPPs. The CPPs were optimized using a numerical method by keeping the CQAs within the desired range (R1–R2: minimize & R3–R5: maximize) as an optimization goal. Optimized chromatographic separation was achieved using a Waters Acquity UPLC BEH C18, 100 mm × 2.1 mm, 1.7 μm column with a gradient mode of elution comprising 20 mM phosphate buffer: ACN 70 : 30, v/v as mobile phase-A and 20 mM phosphate buffer: ACN 30 : 70, v/v as mobile phase-B. The developed method was validated in accordance with ICH guidelines. The validation data conclude that the developed method is specific, accurate, linear, precise, rugged, and robust for the quantification of impurities in BMD topical formulations.
1 January 2013 in Journal of Pharmaceutical and Biomedical Analysis
A stability indicating UPLC method was developed for the quantitative determination of Zolpidem Tartrate (ZT) and its product related variants present in drug substance and drug products. The liquid chromatographic separation was achieved on Acquity UPLC HSS T3-C18 column. All the eight potential variants and the drug were eluted within 8 minutes. A narrow range pH gradient, in combination with organic modifier was used to obtain separation (Rs > 1.5) between critical pairs. There was no placebo interference during the determination of analytes. The method had shown a good and consistent recoveries [98.91 ± 0.55 (mean ± RSD)] with a high degree of intra- and inter-day precision (ANOVA: FCalculated = 0.6498 < FCritical = 3.6823) for the drug. Linear regression analysis data revealed the best R2 values (0.9980–0.9998) and F Siginificance values (p < α = 0.05) for the drug and impurities. The stability-indicating capability of the method was verified by subjecting the drug to hydrolytic, oxidative, photolytic, and thermal stress conditions. LC-MS was used to identify the mass numbers of the degradation products. The m/z values 281 and 227 were matched with zolpidem acid and zolpyridine, respectively. Possible degradation pathways were discussed for the product related variants formed during stress studies.